01/11/2022
Related Posts
STADA set to expand Specialty portfolio with positive CHMP opinion on Kinpeygo orphan medicine for IgAN kidney disease
STADA has taken a significant step towards expanding its Specialty portfolio
STADA delivers double-digit growth in 2019 as it invests to lead Consumer Healthcare and Generics core segments
Corona Survey
Insights into how people in four major European countries are feeling about healthcare issues amid the COVID-19 crises.